Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation
✍ Scribed by Stephen Dummer; Ann Lee; Mary Kay Breinig; Robert Kormos; Monto Ho; Bartley Griffith
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 452 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Infection with a human herpes virus, particularly cytomegalovirus (CMV), has been hypothesized to be a cofactor in the development of atherosclerosis in humans. We investigated the association of prior CMV infection with the presence of atherosclerosis in the coronary arteries of the native heart of 314 individuals undergoing heart transplantation. Age, male gender, race, tobacco use, and previous general and cardiac surgery were also studied as covariables. Factors associated with the presence of coronary atherosclerosis by univariate analysis were age greater than the median of 48 years (odds ratio [OR] = 5.9, 95% confidence intervals [Cl] 3.0–11.6; P < 0.0001), tobacco use (OR = 3.8, 95% Cl 2.1–7.0; P < 0.005), CMV seropositivity (OR = 3.1, 95% Cl 1.8–5.5; P < 0.001), and male gender (OR = 3.0, 95% Cl 1.6–5.4; P < 0.0005). When patients were divided into quartiles based on age, coronary atherosclerosis was shown to be associated with CMV seropositive status only in the youngest quartile of patients (OR = 3.6, 95% Cl 1.4–8.9; P < 0.01) but not in the older three quartiles of patients (OR = 0.9, 95% Cl = 0.3–2.4; P > 0.5). In multiple logistic regression analyses, CMV seropositivity was not a significant independent variable in the whole group of patients (P = 0.13) but remained a significant variable in the youngest quartile of patients (P = 0.01). However, 43% of these younger patients and 29% of all patients with coronary atherosclerosis were seronegative for CMV. We infer that prior CMV infection is not a general risk factor for atherosclerosis, but it may be a cofactor in a subset of younger patients. Further studies are warranted but need to be carefully controlled for confounding variables. © 1994 Wiley‐Liss, Inc.